Nxera Pharma Co., Ltd.
Biotechnology · Healthcare
COO
2 appearances
Latest appearance 2026-08-07
COO
Nxera Pharma Co., Ltd.
Equibles does not estimate personal net worth.
Toshihiro Maeda is recorded as COO at Nxera Pharma Co., Ltd.. Toshihiro Maeda has spoken on 2 earnings calls across 1 company, most recently for Nxera Pharma Co., Ltd. on August 7, 2026. Nxera Pharma Co., Ltd. is classified in the Biotechnology industry within the Healthcare sector.
“I will now provide an overview of our Japan and APAC operation. I am Maeda COO. Thank you very much for today. I will explain the current status for our three main products.”
“Then, I would like to talk about Japan and APAC. Please turn to the next page. First of all, The actual of our first commercially available product PIVLAT and its highlights as of 2025.”
Nxera Pharma Co., Ltd.
COO
Transcript header (unverified)
Nxera Pharma Co., Ltd.
Biotechnology · Healthcare
COO
H1 FY2026 Financial Results
Nxera Pharma Co., Ltd.
FY2025 Financial Results
Nxera Pharma Co., Ltd.